Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial

Manuel Carcao, Michele Schiavulli, Roshni Kulkarni, Pablo Rendo, Meredith Foster, Elena Santagostino, Sandra Casiano, Christoph Königs

Blood Adv (2024) 8 (6): 1494–1503.

https://doi.org/10.1182/bloodadvances.2023011475

Published: 2024

Includes: Supplemental data

Journal Articles

Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU

Kathelijn Fischer, Gili Kenet, Karin Kurnik, Manuel Carcao, Johannes Oldenburg, Torben Stamm-Mikkelsen, Ana Rosa Cid Haro, Minna Koskenvuo, Jan Blatny, Christoph Königs

Blood Adv (2024) 8 (2): 369–377.

https://doi.org/10.1182/bloodadvances.2023011442

Published: 2024

Includes: Supplemental data

Journal Articles

The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A

Christoph Male, Christoph Königs, Sohan Dey, Tadashi Matsushita, Anders Holm Millner, Marek Zak, Guy Young, Gili Kenet

Blood Adv (2023) 7 (4): 620–629.

https://doi.org/10.1182/bloodadvances.2022007529

Published: 2023

Includes: Supplemental data